-+ 0.00%
-+ 0.00%
-+ 0.00%

GC Medical Science Reports KRW 6.82 Billion Derivatives Valuation Loss

PUBT·11/16/2026 12:11:50
Listen to the news
GC Medical Science Reports KRW 6.82 Billion Derivatives Valuation Loss
  • GC Medical Science disclosed a KRW 6.82 billion net derivatives valuation loss for January-September 2026 on Nov. 16.
  • The loss represented 11.34% of equity totaling KRW 60.14 billion.
  • Derivatives valuation losses of KRW 7.59 billion were partly offset by valuation gains of KRW 770.03 million.
  • A rising share price increased the fair value of conversion and redemption rights associated with bonds with warrants.
  • The accounting loss did not result in cash outflows.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GC Medical Science Corp, published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261116902099), on November 16, 2026, and is solely responsible for the information contained therein.